ClinicalTrials.gg
Not yet recruitingNCT06743152Updated Dec 19, 2024

Comparison of the Effects of Synchronous and Asynchronous Telerehabilitation in Patients with Juvenile Familial Mediterranean Fever

An interventional study of Synchronous exercise program and Asynchronous exercise group in Familial Mediterranean Fever (FMF ), Exercise and Telerehabilitation, sponsored by Istanbul University - Cerrahpasa. Not yet recruiting at 1 site in Turkey. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-12-19.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 2 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 20 studies in Familial Mediterranean Fever with a site in Turkey — 7 open to participants now, 8 under way, none of them phase 3. Familial Mediterranean Fever · Turkey.

Planned enrollment
7th of 10
52 · median 60
Started
2024
with 2 others
No phase
4 of 20
2 open now
Registered
14th of 20
by date
Lead sponsor
5 of 20
Istanbul University - Cerrahpasa

Among the 20 studies in Familial Mediterranean Fever with a site in Turkey, this one is the 7th largest by planned enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2024, is one of 4 with no phase, and was the 14th registered.

Familial Mediterranean Fever

61 studies on the registry are indexed under Familial Mediterranean Fever; 27 are open to participants now.

This study's planned enrollment of 52 is above the median of 40 across 27 interventional studies indexed under Familial Mediterranean Fever.

Browse Familial Mediterranean Fever studies →

Open to participants now

7 of the 20 studies in Familial Mediterranean Fever with a site in Turkey are open now, in 3 countries. Each count lists the studies.

All 7 open studies →

Who these studies take

Of the 12 Familial Mediterranean Fever studies recruiting now, 4 (33%) set no upper age limit and 5 (42%) stop at 75 or younger; 10 take children under 18; 3 take healthy volunteers.

This study: 12 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Familial Mediterranean Fever with a site in Turkey, or all of them as a file.
02

Study summary

Our study will be randomized controlled. Familial Mediterranean Fever patients between the ages of 12-18 will be included in the study and will be divided into 2 groups. The first group will be applied a synchronous supervised online exercise program under the supervision of a physiotherapist, and the second group will be applied an asynchronous video-based exercise program. The exercise program will be carried out for 8 weeks, 2 days a week. There will be 3 sets, 8 repetitions in 1 set in the exercise program and will be progressed according to tolerance. In the exercise program, the synchronous group will perform the exercises with the supervision of a physiotherapist via the Zoom application, while the asynchronous video-based group will upload the exercises to the system asynchronously via a channel on YouTube that only patients can access. Feedback will be received from the asynchronous group by phone. Our exercise program will be organized with the progression of exercises such as squat, lunge, stepping, running in place and jumping. The primary outcome measures of the study are the evaluation of fatigue (VAS) and functional capacity (6-Minute Walking Test). Our secondary outcome measures are the evaluation of pain, balance, physical fitness and walking. For the assessment of fatigue: Visual Analog Scale (VAS), PedsQL Multidimensional Fatigue Scale, Fatigue Severity Scale; For the assessment of functional capacity: 6 Minute Walk Test, 30 sec Sit-to-Stand Test, 10-Step Climbing Test, Pacer aebonic fitness test, Half Squat Test; For the assessment of balance: One-Leg Stand Test, Functional Forward Reach Test, Kinvent (K-plate)-K Force measurement evaluation set, Digitsole Smart Insole System for the assessment of walking; For the assessment of physical fitness: FitnessGram test battery; For the assessment of pain: VAS will be used.

03

Conditions studied

  • Familial Mediterranean Fever (FMF )
  • Exercise
  • Telerehabilitation
04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between the ages of 12-18
  • The parent's willingness to have their child participate in the study
  • Being diagnosed with FMF at least 6 months ago
  • Being in an attack-free period
  • Have an internet access
  • Being able to use a computer, tablet or smartphone
  • Have access to a technological device with a camera, microphone and speaker output
  • Being willing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Having any musculoskeletal disease or orthopedic, neurological, psychological disease that may prevent participation in exercise
  • Acute pain for any reason
  • Development of amyloidosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    synchronous telerehabilitation group

    Synchronous telerehabilitation group will be applied a synchronous supervised online exercise program under the supervision of a physiotherapist

    Behavioral: Synchronous exercise program

  • Experimental
    Asynchronous telerehabilitation group

    Asynchronous telerehabilitation group will be applied an asynchronous video-based exercise program.

    Behavioral: Asynchronous exercise group

Interventions

  • BehavioralSynchronous exercise program

    The synchronous exercise group will be conducted online with synchronous supervision under the supervision of a physiotherapist. The exercise program will be performed for 8 weeks, 2 days a week. In the exercise program, 3 sets, 8 repetitions in 1 set will be progressed to 10-12-15-20-25 repetitions according to tolerance. There will be a 1-2 minute rest between sets.

  • BehavioralAsynchronous exercise group

    The Asynchronous Exercise Group will be conducted with a video-based structured exercise program. For the asynchronous video-based group, a closed channel will be created on Youtube that only patients can access, and the exercises will be uploaded to the system asynchronously. In the asynchronous exercise group, how each exercise is performed will be shown in detail by the physiotherapist in the video content.

06

What researchers measure

Primary outcomes

  1. Visuel Analog Scale

    In the evaluation of patient fatigue, patients will be asked to mark on a 100 mm horizontal line. According to VAS, a 0 mm point on this line indicates no fatigue, while a 100 mm point indicates very severe fatigue.

    Time frame: From enrollment to the end of treatment at 8 weeks"

  2. Six Minute Walking Test

    It is a test frequently used to evaluate functional capacity. The distance that patients walk in a 30-meter corridor on a flat surface for 6 minutes will be recorded.

    Time frame: From enrollment to the end of treatment at 8 weeks

Secondary outcomes

  1. PedsQL Multidimensional Fatigue Scale

    It is a measurement method consisting of 18 questions developed to evaluate fatigue in pediatric patients.

    Time frame: From enrollment to the end of treatment at 8 weeks

  2. Fatigue Severity Scale

    It is a tool consisting of 9 questions that evaluates fatigue severity.

    Time frame: From enrollment to the end of treatment at 8 weeks

  3. 30 Second Sit-to-Stand Test

    One of the tests that will be used to test the functional capacity of individuals is the 30-second sit-to-stand test. During the test, patients will be asked to sit with their hands crossed over their shoulders and their feet touching the ground, and to do a full sit-to-stand in this position. The number of correct standing ups within thirty seconds will be recorded as the test score.

    Time frame: From enrollment to the end of treatment at 8 weeks

  4. 10-Step Climbing Test

    In order to evaluate the functional capacity of the patients, they will be asked to quickly climb up and down 10 stairs and the test score will be recorded in seconds.

    Time frame: From enrollment to the end of treatment at 8 weeks

  5. Half Squat Test

    Individuals will be asked to maintain a half squat position on a hard surface, feet shoulder-width apart, hands crossed over shoulders, without shoes, in order to assess their functional capacity. The duration of the squat will be recorded in seconds.

    Time frame: From enrollment to the end of treatment at 8 weeks

  6. Pacer Run Test

    They will be asked to run between two cones in a 20-meter corridor, paying attention to the beeps coming from the voice recorder. The test will start at a slow running speed, and the speed will gradually increase every minute. If individuals cannot reach the cone line the first time when the beep sounds, they will be asked to run in the opposite direction. At the end of the test, the total number of completed laps will be taken as the score, including the laps that were not completed.

    Time frame: From enrollment to the end of treatment at 8 weeks

  7. Single Leg Stand Test

    In order to assess the balance of the subjects, they will be asked to stand on one leg with their hands crossed on their chest and the knee joint flexed at 90 degrees. It will be repeated for both the right and left extremities. The test score will be recorded in seconds.

    Time frame: From enrollment to the end of treatment at 8 weeks

  8. Functional Forward Reach Test

    Individuals will be asked to turn sideways to the wall, flex their arm 90 degrees from the shoulder, and make a fist. The third metacarpophalangeal joint will be marked as the starting point and individuals will be asked to reach forward as much as possible without taking a step or bending their knees. The third metacarpophalangeal joint alignment will be marked again at the last point reached. The distance between the two marked points will be recorded in centimeters.

    Time frame: From enrollment to the end of treatment at 8 weeks

  9. K- Force-Kinvent Measurement and Evaluation Set

    Balance skills will be tested during postures such as squat posture on K-Force plates, single leg and double leg postures with eyes open and closed.

    Time frame: From enrollment to the end of treatment at 8 weeks

  10. Digitsole Pro Smart Insole System

    The walking parameters of individuals will be evaluated with the Digitsole Smart Insole system. Digitsole Pro® smart insole is a valid and reliable measurement tool that allows the individual to evaluate the walking parameters of the individual by being placed inside the shoe worn by the participant. Individuals will be asked to walk wearing smart insoles with sensors inside their shoes. The spatio-temporal and kinematic walking parameters of individuals will be evaluated with the Digitsole Pro system.

    Time frame: From enrollment to the end of treatment at 8 weeks

  11. FitnessGram Test Battery- Sit-up test

    The FitnessGram test battery is a valid and reliable measurement method. Its components include functional capacity, flexibility, muscle strength, body composition and muscular endurance. The FitnessGram test battery will include the Sit-up test, Push-up test, Sit-and-reach test, Trunk lift test and Pacer test. The sit-up test will begin with the patient in a supine position with the knees flexed approximately 140 degrees and the knees slightly apart. The patient will be asked to do sit-ups in accordance with the commands from the voice recorder while the arms are extended next to the body, with the shoulder blades slightly lifted off the ground. The number of sit-ups will be recorded.

    Time frame: From enrollment to the end of treatment at 8 weeks

  12. FitnessGram Test Battery-The push-up test

    The push-up test, individuals will be asked to do push-ups in accordance with the commands from the device with the help of elbow flexion and extension while in the prone position. The number of push-ups done correctly will be recorded. The push-up test provides information about the endurance of the upper extremity muscles.

    Time frame: From enrollment to the end of treatment at 8 weeks

  13. FitnessGram Test Battery-The Sit-Reach test

    The Sit-Reach test: A plate with a length of 50 cm and a width of 45 cm is placed on a box with a length of 35 cm, a width of 45 cm and a height of 32 cm. During the test, individuals will reach forward with their hands as far as they can, with one knee in extension and the other knee in flexion in front of the test box. The evaluation will be repeated for the other side. At the end of the test, the distance the individual reaches will be recorded in cm

    Time frame: From enrollment to the end of treatment at 8 weeks

  14. FitnessGram Test Battery-The trunk lift test

    The trunk lift test will be performed to evaluate trunk extensor muscle endurance. The test will begin with the individual's hands placed under the thighs in a prone position on a flat surface. The subjects will be asked to slowly lift their trunks upwards with their heads. At the end of the test, the distance between the ground and the subjects' chin will be recorded in cm.

    Time frame: From enrollment to the end of treatment at 8 weeks

  15. FitnessGram Test Battery- body composition

    Body mass index will be calculated for body composition.

    Time frame: From enrollment to the end of treatment at 8 weeks

  16. Visuel Analog Scale

    Patients will be asked to mark their pain level on a 100 mm line. 0 mm on the line represents "no pain" and 100 mm represents "very severe pain."

    Time frame: From enrollment to the end of treatment at 8 weeks

07

Study locations

1 site
  • Istanbul University-Cerrahpasa
    Istanbul, Turkey
    • Istanbul University-Cerrahpasa Istanbul University-Cerrahpasa · Contact(0212) 404 03 00
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2024; primary completion for Aug 2025, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 16, 2024
First posted
Dec 19, 2024
StartEst.
Dec 29, 2024
Primary completionEst.
Aug 20, 2025
CompletionEst.
Dec 29, 2026
Last update
Dec 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06743152
Responsible party
Aysenur Namli (MSc, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Dec 19, 2024
Start date
Dec 29, 2024 (estimated)
Primary completion
Aug 20, 2025 (estimated)
Completion
Dec 29, 2026 (estimated)
Last update
Dec 19, 2024

Study contacts

Ayşenur Namlı Şeker
Contact
fzt.aysenurnamli@gmail.com
+90 212 404 03 00

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion